Table 2.
Baseline | 3 weeks | 6 weeks | |
---|---|---|---|
ACT (Choline) | 22.1 ± 3.3 | 22.9 ± 2.8 | 23.4 ± 2 |
ACT (Placebo) | 23.7 ± 1.9 | 23.2 ± 2.5 | |
FEV1 % (Choline) | 75 ± 20.4 | 75.3 ± 19.3 | |
FEV1 % (Placebo) | 76 ± 20 | ||
FEV1/FVC (Choline) | 0.73 ± 0.1 | 0.73 ± 0.1 | |
FEV1/FVC (Placebo) | 0.73 ± 0.1 | ||
FEF25-75 % (Choline) | 71 ± 38.2 | 70 ± 34.2 | |
FEF25-75 % (Placebo) | 71.5 ± 34 |
n = 30
p > 0.86 for all comparisons